Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 23:8:110.
doi: 10.3389/fphys.2017.00110. eCollection 2017.

Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits

Affiliations

Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits

Kyungjoon Lim et al. Front Physiol. .

Abstract

In the present study, we examined the effects of central administration of Urotensin II on blood pressure, heart rate, and baroreceptor heart rate reflexes in conscious normotensive rabbits. Preliminary operations were undertaken to implant a balloon cuff on the inferior vena cava for baroreflex assessments and to implant cannula into the lateral and fourth ventricle. After 2 weeks of recovery cumulative dose response curves to Urotensin II (10, 100 ng, 1, 10, and 100 μg) given into the ventricles, or Ringer's solution as a vehicle were performed on separate days. Injections were given each hour and baroreflex assessments were made 30 min after each administration. Analysis of the dose response curves to Urotensin II compared to vehicle administered into the lateral or fourth ventricle, indicated little change to blood pressure or heart rate. Analysis of the time course to the highest dose over a 30 min period revealed a small (-5 mmHg) depressor response maximal at 10 min when injected into the fourth ventricle but no effect when injected into the lateral ventricle. Baroreflex assessments made at each dose showed that there was no change in baroreflex sensitivity but that an increase in the upper plateau was observed when Urotensin was injected into the lateral ventricle and a tendency for a reduced lower heart rate plateau was observed after fourth ventricle administration. Clonidine administration in the fourth ventricle decreased blood pressure and heart rate, thus confirming catheter patency. In conclusion, our findings suggest that Urotensin II in the forebrain and brainstem may play a role in modulating cardiac sympathetic and vagal baroreflexes but only during large acute changes in blood pressure.

Keywords: Urotensin II (SD1293); baroreflex; blood pressure; central effect; conscious rabbit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Log dose response curves for Urotensin II and vehicle showing the changes in the baroreflex cardiovascular parameters of systolic blood pressure (SBP, mmHg), diastolic blood pressure (DBP, mmHg), mean blood pressure (MBP, mmHg), and heart rate (HR, beats per min), expressed relative to the initial control parameters. Error bars are SEM indicating animal variance between doses within groups.
Figure 2
Figure 2
Average systolic (black), mean (white) and diastolic (gray) arterial pressure (mmHg) and heart rate (b/min) before (control) and after 100 μg Urotensin II administered into the lateral ventricle (A) and into the fourth ventricle (B) in six conscious rabbits (arrow at time 0). *Indicates P < 0.05 compared to control. Error bars indicate the SEM between animals.
Figure 3
Figure 3
Log dose response curves for Urotensin II and vehicle showing the changes in the baroreflex parameters of lower plateau (beats per minute), average curvature (100 mmHg−1), range (beats per min), average gain (beats per min per mmHg), upper plateau (beats per min), and BP50 (mmHg) expressed relative to the initial control parameters. *Indicates P < 0.05, **P < 0.01.
Figure 4
Figure 4
The effect of 1 μg Urotensin II or vehicle in the fourth and lateral ventricles on the baroreflex curve averaged for 6 rabbits as compared to control. *Indicates P < 0.05.
Figure 5
Figure 5
The effect of 10 μg Urotensin II or vehicle (Left) in the fourth and lateral ventricles and the effect of 100 μg Urotensin II or vehicle (Right) on the baroreflex curve averaged for 6 rabbits as compared to control. (*)Indicates P = 0.06, *indicates P < 0.05, **indicates P < 0.01.
Figure 6
Figure 6
Average systolic (black), mean (white) and diastolic (gray) arterial pressure (mmHg) and heart rate (b/min) before (control) and after 5 μg/kg clonidine administered into the fourth ventricle (arrow at time 0) of six conscious rabbits. *Indicates P < 0.05 compared to control. Error bars indicate the SEM between animals.

Similar articles

References

    1. Adams G. P., Ratto M. H. (2013). Ovulation-inducing factor in seminal plasma: a review. Anim. Reprod. Sci. 136, 148–156. 10.1016/j.anireprosci.2012.10.004 - DOI - PubMed
    1. Ames R. S., Sarau H. M., Chambers J. K., Willette R. N., Aiyar N. V., Romanic A. M., et al. . (1999). Human Urotensin-ii is a potent vasoconstrictor and agonist for the orphan receptor Gpr14. Nature 401, 282–286. 10.1038/45809 - DOI - PubMed
    1. Australian Code of Practice for the Care and Use of Animals for Scientific Purposes 7th Edition (2004). Canberra, ACT: Australian Government Publishing Service.
    1. Backstrom T., Pettersson A., Johansson V., Winberg S. (2011). Crf and urotensin I effects on aggression and anxiety-like behavior in rainbow trout. J. Exp. Biol. 214, 907–914. 10.1242/jeb.045070 - DOI - PubMed
    1. Brailoiu G. C., Deliu E., Rabinowitz J. E., Tilley D. G., Koch W. J., Brailoiu E. (2014). Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus. J. Neurochem. 129, 628–636. 10.1111/jnc.12679 - DOI - PMC - PubMed

LinkOut - more resources